New Findings Published in Clinical Nutrition in Partnership with The International Tree Nut Council Nutrition Research & Education Foundation DAVIS, Calif., March 12, 2025 /PRNewswire/ — In a recent study published online in the journal, […]
Tag: Clinical Trials & Medical Discoveries
Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH
RAICHUR, India , March 12, 2025 /PRNewswire/ — Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug (IND) […]
Caliway’s CBL-514 Phase 2 Study (CBL-0202) Accepted for Publication in the Aesthetic Surgery Journal
Advancing Scientific Recognition in Non-Surgical Fat Reduction Caliway’s CBL-514 Phase 2 study (CBL-0202) has been accepted for publication in Aesthetic Surgery Journal (ASJ), the top-ranked journal in aesthetic medicine and plastic surgery. Clinical data (ITT […]
Shilpa Medicare obtient le feu vert du SEC de la CDSCO pour les comprimés d’acide nor-ursodésoxycholique, en vue d’une mise sur le marché pour le traitement de la NASH USA – Français APAC – English APAC – Traditional Chinese USA – English
RAICHUR, Inde, 12 mars 2025 /PRNewswire/ — Shilpa Medicare Limited (BSE : 530549) (NSE : SHILPAMED), l’un des principaux fabricants d’IPA et de formulations, annonce que le comité d’experts du domaine (SEC) de la CDSCO a approuvé son […]
Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH
RAICHUR, India , March 12, 2025 /PRNewswire/ — Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug (IND) […]
